Acumen Pharmaceuticals, Inc.
ABOS
$2.97
-$0.20-6.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 110.20M | 128.40M | 116.87M | 126.61M | 143.37M |
| Total Receivables | 1.25M | 1.09M | 993.00K | 718.00K | 562.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 128.00K | 350.00K | 5.99M | 703.00K | 169.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.94M | 3.26M | 3.79M | 4.12M | 4.30M |
| Total Current Assets | 115.51M | 133.09M | 122.25M | 132.15M | 148.40M |
|
|
|||||
| Total Current Assets | 115.51M | 133.09M | 122.25M | 132.15M | 148.40M |
| Net Property, Plant & Equipment | 152.00K | 197.00K | 243.00K | 288.00K | 335.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 24.00K | 24.00K | 29.00K | 30.00K | 50.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 318.00K | 314.00K | 890.00K | 644.00K | 311.00K |
| Total Assets | 116.01M | 133.63M | 122.83M | 142.22M | 171.90M |
|
|
|||||
| Total Accounts Payable | 13.38M | 1.66M | 554.00K | 682.00K | 2.10M |
| Total Accrued Expenses | 13.55M | 12.84M | 41.05M | 17.18M | 22.46M |
| Short-term Debt | -- | -- | 8.77M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.75M | 14.24M | 8.92M | 3.74M | 142.00K |
| Total Finance Division Other Current Liabilities | 168.00K | 497.00K | 180.00K | 352.00K | 161.00K |
| Total Other Current Liabilities | 168.00K | 497.00K | 180.00K | 352.00K | 161.00K |
| Total Current Liabilities | 46.85M | 29.23M | 30.01M | 21.96M | 24.86M |
|
|
|||||
| Total Current Liabilities | 46.85M | 29.23M | 30.01M | 21.96M | 24.86M |
| Long-Term Debt | 11.90M | 16.92M | 22.40M | 27.05M | 29.88M |
| Short-term Debt | -- | -- | 8.77M | -- | -- |
| Capital Leases | -- | -- | -- | 39.00K | 77.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 58.74M | 46.15M | 52.40M | 49.05M | 54.82M |
|
|
|||||
| Common Stock & APIC | 557.19M | 554.65M | 516.81M | 514.39M | 511.93M |
| Retained Earnings | -499.92M | -467.20M | -446.46M | -421.32M | -394.87M |
| Treasury Stock & Other | -13.00K | 21.00K | 83.00K | 109.00K | 23.00K |
| Total Common Equity | 57.26M | 87.48M | 70.43M | 93.17M | 117.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 57.26M | 87.48M | 70.43M | 93.17M | 117.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.26M | 87.48M | 70.43M | 93.17M | 117.08M |
|
|
|||||